Recruiting
Phase 1

Atezolizumab for Idiopathic Pulmonary Fibrosis

Sponsor:

Cedars-Sinai Medical Center

Code:

NCT05515627

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information